Healthtech startup Temple, founded by Deepinder Goyal, has nearly doubled its valuation to $375 million through a secondary share sale while also rewarding its workforce with its first-ever employee stock ownership plan (ESOP) liquidity programme.
According to Moneycontrol, the latest secondary transaction values the company at $375 million, almost twice its previous valuation of around $190 million. Temple had earlier raised $54 million at that valuation.
The milestone comes as the startup continues to build its flagship health wearable—a forehead-worn device designed to track the body’s metabolic state in real time. Currently available through an early access programme, the device is positioned as a wellness product and is expected to make its commercial debut within the next year, subject to further product validation and development.
Founded by Deepinder Goyal after stepping down as CEO of Eternal, Temple is betting on wearable technology to help people better understand and manage their health. Over the past few months, the company has been steadily expanding its team while accelerating product development ahead of a wider market launch.
Alongside its valuation jump, Temple has also introduced its first ESOP liquidity programme, allowing employees to monetise a part of their stock options. The move places the company among a growing number of Indian startups offering wealth-creation opportunities to their teams.
According to data compiled by Entrackr, nine startups have collectively completed ESOP buybacks worth more than $270 million in 2026 so far. Companies including BrowserStack, Innovaccer, CoinDCX, Unacademy, Tractor Junction, Emversity, Cashfree Payments, Plum, and Kratikal have all launched employee liquidity programmes this year.
More recently, travel fintech startup Scapia also announced an ESOP buyback worth ₹20 crore, highlighting a broader trend of startups sharing value creation with employees as they continue to scale.
Temple’s latest valuation milestone and employee-focused initiative reflect growing investor confidence in India’s emerging healthtech sector, while reinforcing the increasing importance of employee ownership in the country’s startup ecosystem.
